Eulalia Baselga Torres1, José Bernabéu Wittel2, Diego L van Esso Arbolave3, María Isabel Febrer Bosch4, Ángel Carrasco Sanz5, Raúl de Lucas Laguna6, Jesús Del Pozo Losada7, Ángela Hernández Martín8, Lorenzo Jiménez Montañés9, Juan Carlos López Gutiérrez10, Ana Martín-Santiago11, Pedro Redondo Bellón12, Juan Ruíz-Canela Cáceres13, Antonio Torrelo Fernández8, Ángel Vera Casaño14, María Asunción Vicente Villa15. 1. Servicio de Dermatología, Hospital de la Santa Creu i Sant Pau, Barcelona, España. Electronic address: ebaselga@dermik.es. 2. Servicio de Dermatología, Hospital Universitario Virgen del Rocío, Sevilla, España. 3. Pediatría, CAP Pare Claret, Barcelona, España. 4. Servicio de Dermatología, Consorcio Hospital General Universitario de Valencia, València, España. 5. Pediatría, Centro de Salud Potosí, Madrid, España. 6. Servicio de Dermatología, Hospital Universitario La Paz, Madrid, España. 7. Servicio de Dermatología, Complejo Hospitalario Universitario A Coruña, A Coruña, España. 8. Servicio de Dermatología, Hospital Infantil Universitario Niño Jesús, Madrid, España. 9. Servicio de Cardiología Pediátrica, Hospital Universitario Miguel Servet, Zaragoza, España. 10. Servicio de Cirugía Pediátrica Hospital Universitario La Paz, Madrid, España. 11. Servicio de Dermatología, Hospital Universitario Son Espases, Palma de Mallorca, Islas Baleares, España. 12. Servicio de Dermatología, Clínica Universidad de Navarra, Pamplona, Navarra, España. 13. Pediatría, Centro de Salud Virgen de África, Sevilla, España. 14. Servicio de Dermatología, Hospital Regional Universitario Carlos Haya, Málaga, España. 15. Servicio de Dermatología, Hospital Sant Joan de Deu, Barcelona, Universidad de Barcelona, Esplugues de Llobregat, Barcelona, España.
Abstract
INTRODUCTION: Infantile haemangiomas are benign tumours produced by the proliferation of endothelial cells of blood vessels, with a high incidence in children under the age of one year (4-10%). It is estimated that 12% of them require treatment. This treatment must be administered according to clinical practice guidelines, expert experience, patient characteristics and parent preferences. METHODS: The consensus process was performed by using scientific evidence on the diagnosis and treatment of infantile haemangiomas, culled from a systematic review of the literature, together with specialist expert opinions. The recommendations issued were validated by the specialists, who also provided their level of agreement. RESULTS: This document contains recommendations on the classification, associations, complications, diagnosis, treatment, and follow-up of patients with infantile haemangioma. It also includes action algorithms, and addresses multidisciplinary management and referral criteria between the different specialities involved in the clinical management of this type of patient. CONCLUSIONS: The recommendations and the diagnostic and therapeutic algorithms of infantile haemangiomas contained in this document are a useful tool for the proper management of these patients.
INTRODUCTION: Infantile haemangiomas are benign tumours produced by the proliferation of endothelial cells of blood vessels, with a high incidence in children under the age of one year (4-10%). It is estimated that 12% of them require treatment. This treatment must be administered according to clinical practice guidelines, expert experience, patient characteristics and parent preferences. METHODS: The consensus process was performed by using scientific evidence on the diagnosis and treatment of infantile haemangiomas, culled from a systematic review of the literature, together with specialist expert opinions. The recommendations issued were validated by the specialists, who also provided their level of agreement. RESULTS: This document contains recommendations on the classification, associations, complications, diagnosis, treatment, and follow-up of patients with infantile haemangioma. It also includes action algorithms, and addresses multidisciplinary management and referral criteria between the different specialities involved in the clinical management of this type of patient. CONCLUSIONS: The recommendations and the diagnostic and therapeutic algorithms of infantile haemangiomas contained in this document are a useful tool for the proper management of these patients.